The Latest Breaking News from Merck

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments

Pharma has a "choice": Negotiate with HHS or pay $10 million "tax" per day.

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

The lawsuit argues that the negotiation program violates the Fifth Amendment by not paying the company “just compensation” for its products.

Merck say “30-plus” jobs are expected to add to an existing workforce of 99.

The expansion plan should create nearly 500 new jobs in Glasgow and Stirling

During times of uncertainty, an investor can use a covered call to deliver downside protection while capturing upside gains. Here’s how it works.

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. Stock indexes Monday posted moderate gains. An increase in...

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. U.S. stock indexes this morning are mixed. An increase...